• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Medtronic

Researchers’ bionic pancreas outperforms standard insulin pump therapy

December 21, 2016 By Sarah Faulkner

Researchers from Boston University have developed a bionic pancreas system that outperformed conventional insulin pump therapy for patients with type 1 diabetes, according to a trial conducted at Massachusetts General Hospital. The team’s work was published in The Lancet.  This device is the latest development in the race to make an entirely closed loop insulin pump system, […]

Filed Under: Clinical Trials, Diabetes, Drug-Device Combinations, Featured, Research & Development, Uncategorized Tagged With: Beta Bionics, Boston University, Massachusetts General Hospital, Medtronic

Medtronic secures Health Canada license for MiniMed 630G system

October 21, 2016 By Sarah Faulkner

Medtronic Minimed 630g

Medtronic (NYSE:MDT) subsidiary Medtronic Canada said today that it landed a license with Health Canada for its MiniMed 630G insulin pump system for patients with diabetes mellitus. The Fridley, Minn.-based company said it interviewed more than 1,000 diabetes patients to better understand the features they look for in an insulin pump. The final product has a […]

Filed Under: Diabetes, Drug-Device Combinations, Featured, Regulatory/Compliance Tagged With: Health Canada, Medtronic

Report: Drug device market to reach $1.8B by 2024

October 5, 2016 By Sarah Faulkner

The global drug device combination market is expected to reach $17.7 billion by 2024, according to a new report from Grand View Research. The report points to minimally invasive alternatives like transdermal patches as high-impact growth drivers in the industry. As researchers develop these products, regulatory agencies have taken notice and the report notes that […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured Tagged With: Boston Scientific, Medtronic

Ablative Solutions wins FDA nod for Phase II chemical denervation trial

September 13, 2016 By Sarah Faulkner

Ablative Solutions

Ablative Solutions said today that the FDA approved a Phase II trial of its chemical denervation system for hypertension under its investigational new drug application. The trial, called Target-BP I, will evaluate the efficacy of Ablative’s Peregrine infusion ablation system, which uses ethanol to interrupt signals from sympathetic nerves in the renal artery to control […]

Filed Under: Clinical Trials, Drug-Device Combinations, Food & Drug Administration (FDA) Tagged With: Ablative Solutions, Hypertension, Medtronic, St. Jude

Medtronic wins CE Mark for In.Pact Admiral DCB for end-stage renal disease

January 11, 2016 By Fink Densford

Medtronic (NYSE:MDT) said today its In.Pact admiral drug eluting balloon won CE Mark approval in the European Union for arteriovenous access to help maintain hemodialysis access in patients with end-stage renal disease. The device is now cleared for preventing restenosis in hemodialysis access sites by opening up the artery and delivering paclitaxel to the vessel wall. […]

Filed Under: Drug-Device Combinations Tagged With: Medtronic

Diabetes: Medtronic furthers the quest for an artificial pancreas

June 15, 2015 By Fink Densford

Medtronic (NYSE:MDT) and Intarcia Therapeutics were in the spotlight at the American Diabetes Assn.’s annual scientific sessions conference in Boston last week, revealing new medical device developments in the fight against diabetes. Medtronic took center stage, announcing new developments for its artificial pancreas program, touting positive data from a user study of its MiniMed 640g and revealing plans to collaborate […]

Filed Under: Clinical Trials, Drug-Device Combinations, Research & Development Tagged With: Becton Dickinson, GI Dynamics, Glytec, Intarcia Therapeutics, Medtronic, Valeritas Inc.

  • « Go to Previous Page
  • Go to page 1
  • Interim pages omitted …
  • Go to page 18
  • Go to page 19
  • Go to page 20

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Signup for the newsletter

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing & Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS